Your browser doesn't support javascript.
loading
Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therapeutic drugs.
Brumskill, Sarah; Barrera, Lawrence N; Calcraft, Peter; Phillips, Caroline; Costello, Eithne.
Affiliation
  • Brumskill S; Institute of Translational Medicine, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, 2nd Floor Sherrington Building, Ashton Street, Liverpool, L69 3GE, UK.
  • Barrera LN; Redx Oncology, Alderley Park, Macclesfield, Cheshire, UK.
  • Calcraft P; Institute of Translational Medicine, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, 2nd Floor Sherrington Building, Ashton Street, Liverpool, L69 3GE, UK.
  • Phillips C; Redx Oncology, Alderley Park, Macclesfield, Cheshire, UK.
  • Costello E; Redx Oncology, Alderley Park, Macclesfield, Cheshire, UK.
J Physiol Biochem ; 79(1): 223-234, 2023 Feb.
Article in En | MEDLINE | ID: mdl-34865180
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal / Cancer-Associated Fibroblasts Type of study: Diagnostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal / Cancer-Associated Fibroblasts Type of study: Diagnostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Year: 2023 Type: Article